











Received: 20 Aug 2014 Revised and Accepted: 22 Sep 2014 
Department of Pharmaceutics, Gurunanak College of Pharmacy, Kamptee road, India, Maharashtra, Nagpur 440026 
 Email: neetabramhe1990@gmail.com  
ABSTRACT 
Objective: The study elaborates isolation of mucilage from Lepidium sativum seeds and explores it as a tablet binder.  
Methods: The mucilage from seed was extracted by precipitation of soaked and blended seed in acetone. The mucilage was evaluated for its binding 
properties in tablets prepared by wet granulation and direct compression method. The prepared tablets were evaluated for hardness, thickness, 
friability, disintegrating time and in-vitro drug release and compared with established binder like starch, PVP K-30, HPMC, MCC.  
Results: The results of isolated mucilage from Lepidium sativum seeds as a binder were very promising. The results indicated that mucilage is 
required in concentration as low as 2% for wet granulation and 4% for direct compression to give equivalent binding effect.  
Conclusion: Lepidium sativum seed mucilage [LSM] shows promising potential for its application as a binder in the tablet formulation. Low 
concentration of LSM as binder would also help to reduce cost of formulation. 
Keywords: Lepidium sativum mucilage, Binder, Natural excipients. 
 
INTRODUCTION 
Agents used to impart cohesive quantities to the powdered material 
are referred to as binders or granulators. They impart cohesiveness 
to the tablet formulation that ensures the intactness of the tablet 
after compression, as well as improve the free- flowing quality by 
the formulation of granules of desired hardness and size [1]. 
Mucilages are polyuronides consisting of sugar and uronic acid 
units. They are usually formed from the cell wall or deposited on it 
in outer layers. They swell in water and form sticky and viscous 
solution[2]. These plant based material have been utilized as 
viscosity enhancers, stabilizers, disintegrants[3], solubilisers, 
emulsifiers [4], suspending agents [5], gelling agents [6] and 
bioadhesives, binders in different pharmaceutical dosage forms like 
matrix controlled system, film coating agents, buccal films, 
microspheres, nanoparticles, viscous liquid formulations like 
ophthalmic solutions, suspensions, implants and their applicability 
and efficacy has been proven[7-9].  
Lepidium sativum (garden cress) is an annual herb, belonging to 
Brassicaceae family. It is a fast growing, edible plant botanically 
related to watercress and mustard and sharing their peppery, tangy 
flavor and aroma. Seeds, leaves and roots are economically 
important, however, the crop is mainly cultivated for seeds. In some 
regions garden cress is known as garden pepper cress, pepper grass 
or pepperwort. It is also known as asalio or chandrasur in India and 
it is an important medicinal crop in India. Garden cress is a perennial 
plant, and an important green vegetable consumed by human 
beings, most typically as a garnish or as a leaf vegetable [10].
Different seed mucilage has been evaluated for binding property. M. 
Kamble et al evaluated binding property of Ocimum tenuiflorum [13], 
A. Waghmare et al evaluated binding property of flax seed mucilage 
[14], N. Patel evaluated binding property of Cydonia vulgaris[15]. 
Binding property of Eulophia campestris [16], Prosopis juliflora [17] 
etc has also been evaluated. But there is need of plant based 
polymers which are safe, stable, economics in production, and shows 
more promising binding property which can be used in less 
concentration. No significant work has been reported on Lepidium 
sativum for its use as a tablet binder. Hence the present study is 
concerned to explore Lepidium sativum seed mucilage [LSM] for its 
binding property by formulating tablet prepared by wet granulation, 
direct compression method. 
They 
show various properties such as anti-asthmatic, ant scorbutic, 
aperients, diuretic, stimulant, chemo protective effects, anti-diabetic, 
anti-hypertensive, fracture healing, hepatoprotective activity, 
pesticidal activity, antidiarrheal activity etc [11,12]. 
MATERIALS AND METHODS 
Seed of Lepidium sativum were collected from the local market, 
Nagpur, Maharashtra. The plant material (seeds) was authenticated 
with the help of herbarium sheet by Dr. N. M. Dongarwar, 
Department of Botany, R. T. M. Nagpur University, Nagpur. The 
specimen numbers given to the authenticated herbarium sheet were 
9890. Voucher specimen of the plant is deposited in the Department 
of Botany, R. T. M. Nagpur University, Nagpur. Etoricoxib was 
obtained from ZIM Laboratories (Nagpur, India), as a gift sample. All 
the other materials used in the study were of analytical grade. 
Extraction of the mucilage from Lepidium sativum seeds [18] 
100 g of Lepidium sativum seeds were soaked in 800 ml of distilled water 
for 12 hrs. The soaked seeds were blended for 15 min at about 2000 
rpm. Blended seeds were then filtered through muslin cloth. Additional 
200 ml water was added to the seeds and again blended and refiltered 
through muslin cloth to get maximum yield. To the filtrate [800 ml] 
equivalent amount of acetone was added to allow precipitation of 
mucilage. White supernatant coagulant mass separated after 
precipitation was filtered through the muslin cloth. Precipitated 
mucilage was dried in tray dryer [Labotech] at temperature not 
exceeding 60°c for 16 hr. Mucilage obtained was converted into powder 
by size reduction. Obtained powder was sieved using 80# sieve. The % 
yield, pH, and total microbial load [19] of mucilage were calculated. 
Formulation of tablet 
Wet granulation method 
Mucilage solution of concentration 1%, 2%, 3% was prepared by 
dispersing the LSM in water. All the tablet ingredients were weighed 
and mixed geometrically. Dry mixing was carried out using mortar 
and pestle. Then the binder solutions [1%, 2%, and 3%] were added 
and mixed well to form a wet mass. The wet mass was then passed 
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through sieve No. 16 and dried at the temperature not exceeding 
45°c in a hot air oven. These resultant granules were passed through 
sieve No. 22. Talc and magnesium stearate were uniformly mixed 
with above mixture and then evaluated for pre compression 
parameters. Tablets were compressed using 8 mm round flat 
punches with 6 tons compression pressures on 12 station tablet 
machines. The same method was followed in the preparation of 
tablets [B4, B5] using starch 2% w/w and PVP K-30 2% w/w 
concentration as a binder. The formulations of tablets are shown in 
Table 1. 
 










(2% PVP- K30) 
Etoricoxib 120 120 120 120 120 
LSM 1% (q. s) 2% (q. s) 3%(q. s) - - 
Starch - - - 2% (q. s) - 
PVP k-30 - - - - 2%(q. s) 
Lactose 156 156 156 156 156 
SSG 12 12 12 12 12 
Magnesium stearate 6 6 6 6 6 
Talc 6 6 6 6 6 
Total weight 300 300 300 300 300 
 







D4(PVP k30) 4% D5(MCC) 
4% 
Etoricoxib 120 120 120 120 120 
LSM 4.4 8.8 - - - 
HPMC - - 8.8 - - 
PVP k-30 - - - 8.8 - 
MCC - - - - 8.8 
Lactose 166.8 162.4 162.4 162.4 162.4 
Magnesium state 4.4 4.4 4.4 4.4 4.4 
Talc 4.4 4.4 4.4 4.4 4.4 
Total weight 300 300 300 300 300 
* All quantity are in mg 
 
Direct compression method 
All the powders were passed through 80# mesh sieve. Weighed 
quantity of drug and excipients was mixed thoroughly by blending 
for 15 min.  
Tablets were compressed using 8 mm round flat punches on 12 
station tablet machine. The formulations of tablets are shown in 
Table 2. 
Evaluation of tablet 
Drug mucilage compatibility study 
The mucilage and Etoricoxib were mixed in 1:1 ratio. This mixture 
was mixed with KBr. The infra-red spectrum was recorded using 
FTIR (Shimadzu). The scanning range was 400 to 4000 cm-1
Evaluation of flow properties [20 -22] 
. 
Bulk and tapped densities 
Pre-weighed, pre-sieved quantity of tablet powder and granules 
were poured into a graduated cylinder, and the volume was 
recorded. The bulk and tapped densities were calculated. 
Carr's index and Hausner’s ratio 
Carr's index and Hausner’s ratio were calculated from the bulk and 
tapped densities [23]. 
Angle of repose 
The angle of repose was determined by the fixed height funnel 
method [24]. 
Post compression properties [20, 21, 25] 
Uniformity of weight 
20 tablets weighed were determined by using an electronic balance 
within ±1 mg. Determinations were made in triplicate.  
Hardness 
The hardness of the tablets was determined by diametric 
compression using a Hardness testing apparatus [Monsanto type]. 
Determinations were made in triplicate.  
Friability 
20 tablets were weighed and placed in Roche friabilator [Camp-bell 
Electronics, Mumbai]. Which were then operated for 1000 
revolutions. The tablets were then dusted and reweighed. 
Percentage friability was calculated from the loss in weight. 
In-vitro disintegration test [25] 
The test was carried out on 6 tablets using tablet disintegration tester 
in distilled water at 37ºC ± 2ºC as a disintegration media and the time 
in second taken for complete disintegration of the time in taken for 
complete disintegration of the tablet with no palpable mass remaining 
in the apparatus was measured in seconds. 
In- vitro dissolution profile [26, 27] 
To study the effect of binding agent on dissolution profile of drug in-
vitro dissolution studies was carried out. Dissolution rate of Etoricoxib 
from various tablets was studied using USP XXIII six-station 
dissolution rate test apparatus [DISSO 2000, LABINDIA] with paddle 
stirrer. The dissolution rate was studied by placing tablet containing 
Etoricoxib in 900 ml 0.1 M HCl [pH 1.2] maintained at 37±0.5°c at 50 
rpm. Sample of 5 ml was withdrawn at pre-determined intervals, 
filtered through whatman filter paper. 5 ml of fresh dissolution 
medium was added to the flask to maintain sink condition. The sample 
were diluted and estimated spectrophotometrically at 234 nm by 
using ELICO-167 Double beam UV spectrophotometer. 
Accelerated stability study 
Stability studies for optimized formulations were carried out. The tablet 
was wrapped in aluminum foil of thickness 0.04 mm and stored for three 
months at accelerated condition [temperature of 40°c±2°c and relative 
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humidity of 75±5% RH]. Hardness, thickness, weight variation, friability 
and disintegrating time were then estimated. 
RESULTS AND DISCUSSION 
Extraction of the mucilage from Lepidium sativum seeds 
The mucilage was extracted by the method which was simple and 
cost effective. The percentage yield of mucilage was found to be 12% 
w/w. pH of mucilage 1% w/v dispersion in water was found to be 
5.56. The microbial count for LSM was found to be 249 colonies and 
only 1 fungal count was observed during total microbial load study 
of LSM. Also there was no change observed in mucilage throughout a 
study period. In case of excipients from natural origin, the total 
aerobic count should not be more than 1000 cfu/g and total fungal 
count should not be more than 100 cfu/gm [28]. Result shows that 
the total microbial load of LSM was within the limit. And hence 
mucilage was stable and had the good shelf life. 
Drug mucilage compatibility study 
Compatibility testing between drug and LSM was carried out using 
FTIR. The spectra with results are shown in Fig. 1. The FTIR spectra 
showed that the drug and mucilage were compatible with each other.
 
 
Fig. 1a: IR spectrum of Etoricoxib 
 
 
Fig. 1b: IR spectrum of LSM mucilage 
 
 
Fig. 1c: IR spectrum of Etoricoxib+LSM 
 
 
Evaluation of flow properties 
Lepidium sativum mucilage was investigated as a binder in tablet 
prepared by wet granulation method and its binding property was 
compared with established binder such as Starch, PVP K-30. The 
flow properties of the prepared granules [wet granulation] using 
LSM as tablet binder was studied and results are shown in Table 3. 
Angle of repose, Carr’s index, and hausner ratio were selected as the 
flow indicating parameters.  
They reflect the effect of bulk density, particle size, surface 
characters and moisture content of the powder flow [29]. Angle of 
repose of all formulation was found to between 29.70 to 30.52, bulk 
density in the range of 0.42 to 0.52, tapped density between 0.58 to 
0.65, Carr’s index% in range of 13.37 to 20.47, hausner ratio 
between 1.04 to 1.18. The above result shows that the prepared 
granules exhibited good flow property. LSM mucilage as tablet 
binder in direct compression method were evaluated and compared 
with established binder such as HPMC, PVP K-30, and MCC. Table 4 
shows the results of evaluation of pre compression properties. Angle 
of repose of all the formulations was found to be in the range of 
22.21 to 23.55. Bulk density in the range of 0.42 to 0.73 g/cc, tapped 
density between 0.82 to 0.95 g/cc, Carr’s index in the range 18.61 to 
24.69 %. Hausner ratio between 1.22 to 1.32. Indicating fair to 
passable flow properties for all the powder mixtures. Result 
indicated that use of LSM as a binder does not affect the flow 
property of powder. 
 
Table 3: Pre compression parameters of granules B1-B5 
S. 
No. 
Formulation code Angle of repose (θ) Bulk density (g/cm3 Tapped density (g/cm) 3 Carr’s index % ) Hausner Ratio 
1. B1 30.04±0.47 0.52±0.02 0.65±0.02 19.72±0.68 1.18±0.8 
2. B2 29.70±0.58 0.48±0.01 0.63±0.05 14.89±0.11 1.12±0.01 
3. B3 29.70±0.58 0.47±0.04 0.58±0.03 13.37±0.49 1.14±0.01 
4. B4 30.52±0.91 0.44±0.12 0.62±0.10 13.74±0.25 1.04±0.04 
5. B5 30.43±0.93 0.42±0.11 0.54±0.11 20.47±0.77 1.14±0.02 
 
Table 4: pre compression parameter of powder D1-D5 
S. 
No. 





) index % 
Hausner Ratio 
1. D1 22.38±0.8 0.42±0.04 0.825±0.06 23.97±0.7 1.22±0.4 
2. D2 23.17±0.2 0.69±0.02 0.92±0.03 24.69±0.4 1.32±0.02 
3 D3 23.55±0.07 0.71±0.03 0.91±0.02 21.21±0.2 1.23±0.05 
4 D4 23.2±0.5 0.71±0.02 0.91±0.02 18.61±0.5 1.23±0.05 
3. D5 22.21±0.2 0.73±0.01 0.95±0.03 24.08±0.4 1.31±0.01 
Each value represent the mean ± standard deviation (n=3) 
 
Post compression properties 
After evaluation of pre compression parameters, tablets were 
compressed using rotary 12 station tablet machine (CEMACH). 
Compressed tablets were then evaluated for physical parameters like 
hardness, thickness, weight variation, friability. Post compression 
properties of formulated tablets using natural and synthetic binders as 
standard are shown in Table 5 and Table 6.  
Average weight of tablets was found to be in the range of 302-304 mg. 
For all batches % deviation was observed within the limit. The average 
thickness of formulated tablet was found to be in the range of 4.15- 
4.36 mm within the limit. The friability values increases with decrease 
in binder concentration of LSM in both wet granulation and direct 
compression method as shown in Fig. 2 and Fig. 3. But over all 
friability values were less than specified limits (1%) which indicate 
tablets can withstand the mechanical shock during handling. 
 
Table 5: Post compression parameter of the tablet formulation B1-B 
S. No. Formulation Code Thickness (mm) weight variation (mg) Disintegrating time 
1. B1 4.26±0.09 304±0.04 1 min35 sec 
2. B2 4.34±0.07 304±0.04 1 min52 sec 
3. B3 4.31±0.08 303±0.06 1 min55 sec 
4. B4 4.29±0.09 304±0.08 1 min40 sec 
5. B5 4.36±0.06 302±0.07 1 min33 sec 
Each value represent the mean ± standard deviation (n=3) 
 
Table 6: post compression parameters of tablet formulation D1-D2 
S. No. Formulation Code Thickness (mm) Weight variation (mg) Disintegrating time 
1. D1 4.29±0.03 301±0.05 8 min 16 sec 
2. D2 4.28±0.06 304±0.08 5 min 25 sec 
3. D3 4.16±0.04 303±0.07 16 min 20 sec 
4. D4 4.24±0.12 304±0.05 15 min 50 sec 
5. D5 4.15±0.8 302±0.06 6 min 10 sec 
Each value represent the mean ± standard deviation (n=3) 
Kilor et al. 




Fig. 2: Effect of binder on friability of tablet by wet granulation method. 
 
Fig. 3: Effect of binder on friability of tablet by direct compression method. 
 
 
Fig. 4: Effect of hardness of tablet prepared by wet granulation method. 
 
 
Fig. 5: Effect of binder on hardness of tablet prepared by direct compression method 
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Fig. 6: In- vitro drug release of Etoricoxib B2, D2 and marketed tablet. 
 
Hardness of tablets 
The hardness of the tablet formulated by wet granulation method 
varies between 3.68-5.56 kg/cm2. The hardness of the tablet 
increases with increase in percentage of LSM binding agent. Result 
shows that LSM binder is more effective binder compared to starch 
and PVP-K30. Also the amount of LSM binding solution required is 
comparatively less than other binder due to its viscous and sticky 
nature. LSM was used as a dry binder in formulation. The hardness 
of the tablet varies between 3.33-5.2 kg/cm2
In-vitro disintegration test 
. Hardness observed in 
formulation was acceptable and comparatively better hardness than 
HPMC, PVP- K30, MCC was observed as shown in Fig.4. The binder 
property of LSM mucilage in direct compression method was found 
less and required in more concentration than binding property of 
mucilage used in wet granulation method shown in Fig. 5. This may 
be due to the viscous and colloidal solution formed when mucilage 
was dispersed in water which enhances its binding property in the 
wet granulation. 
As per IP monograph the disintegration time for uncoated tablet 
must be within 15 min. Disintegrating time for tablet formulated by 
wet granulation varied from 33 to 55 sec (Table 5). Whereas in 
direct compression tablet formulation disintegrating time for tablet 
without disintegrating agent varied from 4 min 10 sec to 5 min 25 
sec. (Table 6) i. e. fast disintegration of tablets was observed when 
LSM mucilage was used as binder in dry state at 4% concentration. 
The result indicates that the LSM mucilage have ability to act as 
binder as well as disintegrating agent when used in dry state. 
In- vitro dissolution profile 
The in -vitro dissolution profiles of Optimized 2% LSM mucilage as 
tablet binder tablet prepared by wet granulation technique and 
optimized 4% LSM mucilage as tablet binder in direct compression 
method were compared with that of marketed 120 mg Etoricoxib 
tablet. In vitro dissolution studies on the formulation were carried 
out in 0.1 N HCl. The dissolution profile is depicted in Fig. 6. From 
the result it was observed that above 80 % of drug was released in 
60 min. 
Accelerated stability study 
Accelerated stability studies were carried out as per ICH guidelines. 
Optimized Formulation B2 and D2 did not show the change in color, 
texture and other physical parameters of tablet during the study 
period. This indicates that the prepared tablets are stable at 
accelerated storage conditions. 
CONCLUSION 
From the result, it can be concluded that Lepidium sativum mucilage 
is less susceptible to microorganism hence had the good shelf life 
and can be extracted easily by simple cost effective method with 
good % yield. LSM can be used as a binding agent in tablet 
formulation 2% concentration in wet granulation and 4% in direct 
compression for the preparation of uncoated tablets. Also the 
binding property increased and friability decreased with increase in 
concentration of LSM mucilage. 
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